MedCity News

JANUARY 29, 2024

When it comes to AI, the consensus is that healthcare organizations have an opportunity right now to take an enterprise-wide approach that encompasses everything from workforce to infrastructure to governance and beyond. Here are these ten essential elements of an enterprise-wide AI strategy for healthcare organizations.

Government 105

Government Healthcare Healthcare Biopharma 105

Clarivate

JANUARY 8, 2024

The annual Clarivate Drugs to Watch report for 2024 features 13 new therapeutics with standout commercial and/or clinical potential. The year 2024 is shaping up to be the best of times and the worst of times for the pharma industry,” said Henry Levy, President, Life Sciences & Healthcare at Clarivate.

Marketing 59

Marketing Patients Healthcare Healthcare 59

PM360

APRIL 22, 2024

With healthcare professionals becoming less accessible to biopharma reps, the emphasis has shifted toward patient empowerment. Patients today are knowledgeable and actively participate in deliberations about their healthcare, equipped with information from sources that may or may not be accurate and trustworthy.

Patients 52

Patients Biopharma Ethics Marketing 52

PM360

SEPTEMBER 18, 2024

Varady has spent the last 20 years leading integrated marketing campaigns for biotech and healthcare companies in both U.S. His experience leading large-scale agency accounts for top 10 biopharma companies has led to the successful commercialization of products across a wide array of therapeutic categories. Conshohocken, Pa.,

Marketing 52

Marketing Media Healthcare Healthcare 52

Clarivate

SEPTEMBER 11, 2024

Though there is no cure for the disease, people with Alzheimer’s can receive personalized, multimodal care and support to delay deterioration of their functional status and quality of life and alleviate the burden imposed on their care partners (Emblad, 2021; Bayly, 2021; Xiang, 2024). Food and Drug Administration, 2023 and 2024).

Food and Drug Administration 59

Food and Drug Administration Pharmacology Food FDA 59

PM360

MAY 10, 2024

May 9, 2024 /PRNewswire/ — VUE Health, a Boston-based healthcare advertising agency, has hired Zara Baker as Chief Digital Innovation Officer. Before that, she was the head of omnichannel strategy at Ionis Pharma and held senior digital roles at various healthcare and biopharma companies. SOURCE VUE Health

Healthcare 52

Healthcare Healthcare Biopharma Engineering 52

Clarivate

SEPTEMBER 17, 2024

In the first half of 2024, the biotech industry is witnessing early signs of a rebound in financing and dealmaking activities. While the industry may not see the record-breaking highs of the past, it remains poised for growth and success as it continues to shape the future of healthcare. Please join us – you can register here.

Pharma 59

Pharma Competition Healthcare Healthcare 59

PM360

MAY 21, 2024

sarah.caldwell@veeva.com SARAH CALDWELL General Manager Veeva Crossix Analytic Consumers’ TV viewing habits are changing, and streaming video continues to catapult in popularity, unearthing new opportunities for biopharma advertisers to reach patients in more targeted ways. According to Nielsen, streaming accounts for 38% of viewership hours.

Media 105

Media Healthcare Healthcare Marketing 105

PM360

OCTOBER 8, 2024

The high-profile appointment follows the merger of Bioclinica DSS, MyMeds&Me and Commonwealth Informatics under the Qinecsa brand two years ago, and the recent addition of Insife to the group in Q1 2024. The business is supported by investment from Stanley Capital Partners.

Leads 52

Leads Safety Biopharma Management 52

pharmaphorum

JANUARY 9, 2023

Biopharma and healthcare group Chiesi Farmaceutici S.p.A. The development is for expansion of the company’s in-house drug development of biologicals and rare disease targeting and the site is due to become operational from 2024, with FDA, IFA, and EMA approvals due to be sought for 2025. in an all-cash transaction at $14.50

Pharma 97

Pharma Biopharma Management Medicine 97

PM360

SEPTEMBER 30, 2024

The 2024 Sparkle of Hope event will be on November 14 at 5:30pm in Pompton Plains, NJ. And yet drugs remain the most cost-effective part of the healthcare system because they help keep people out of nursing homes and expensive hospital care.

Biopharma 52

Biopharma Patients Marketing Healthcare 52

PM360

APRIL 22, 2024

In this issue, we take a closer look on the importance of patient education to Healthcare Professionals and navigating the challenges that arise. With an ever- increasing demand for their time and attention, it is more difficult than ever for biopharma representatives to convey their message to the physician audience.

Education 59

Education Physicians Healthcare Healthcare 59

PM360

JUNE 24, 2024

This fuels an enormous need for effective patient communication and education as new therapies move through the biopharma pipeline. Those of us in the biopharma industry know how fraught drug development can be. As the saying goes, they are individually rare but collectively common. Many people, cumulatively, are affected.

Marketing 52

Marketing Patients Food and Drug Administration Digital Media 52

PM360

AUGUST 26, 2024

Fortune 500s or Start-Ups; what are the opportunities and challenges for top school business graduates to consider for the Healthcare/Pharma/Biotech vertical? A: (Galeota) MIT Sloan’s and all MIT students should consider the tremendous career opportunities that the Healthcare/Pharma/Biotech vertical offers.

Distribution 52

Distribution Biopharma Healthcare Healthcare 52

Clarivate

SEPTEMBER 5, 2024

This blog summarizes a portion of the data collected, which was previously shared in a poster presented at the May 2024 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Conference (Read the poster ).

Insurance 52

Insurance Marketing Manufacturing Prescription 52

Clarivate

MAY 14, 2024

The company filed for marketing approval of their semaglutide biosimilar for the treatment of T2D with the National Medical Products Administration (NMPA) in April 2024, and this is expected to amplify clinical development of semaglutide biosimilars from domestic manufacturers in the next two to three years.

Manufacturing 52

Manufacturing Marketing Leads Medicine 52

Clarivate

OCTOBER 31, 2023

Plenty of biotech companies are happy to take a pharma deal presently to extend their financial runway into 2024, 2025, and 2026, said Williamson, “and if that means not retaining significant rights, so be it.” on making these steps a reality to ensure you create the best deal for your company and customers.

Pharma 52

Pharma Biopharma Marketing Healthcare 52

Clarivate

DECEMBER 6, 2022

healthcare provision landscape, integrated delivery networks, or IDNs, are differentiating their offerings by adding outpatient treatment centers, pursuing National Cancer Institute designations and investing in value-based care. Christopher Silva, Senior Healthcare Research Analyst. Pillo, Senior Healthcare Research Analyst.

Networking 52

Networking Healthcare Healthcare Competition 52

Clarivate

JUNE 21, 2024

However, we are also deliberately adopting a cautious approach (Cochrane, 2024).” References Cochrane, 2024. Available: [link] [Accessed 17/06/2024]. CRDs guidance for undertaking reviews in healthcare. Cochrane announces new policy on AI generated content [Online]. Cochrane Crowd [Online]. Available: [link] [Accessed].

Training 81

Training Government Medical science Ethics 81

Clarivate

JULY 7, 2024

Clarivate partnered with members of ABPI and other trade associations to analyze the survey results and co-develop a peer-reviewed manuscript (published on the TIRS (DIA) journal in March 2024).

Pharmaceutical 52

Pharmaceutical Consulting Marketing Management 52

European Pharmaceutical Review

OCTOBER 8, 2024

CPHI Milan, the premier international pharmaceutical event, will be held from 8 to 10 October 2024 at Fiera Milano, Italy. However, the venture capital branches of leading pharmaceutical firms are proving to be innovation engines, vital in fostering advances and addressing key healthcare issues.

Pharma 52

Pharma Manufacturing Pharmaceutical Management 52

PM360

JUNE 24, 2024

But the role of AI in healthcare will go beyond this. healthcare, with its 17% share of GDP, is “the most disruptable industry in the world,” and “the first big carcass that AI is going to start to feed on.” Efficiencies with AI As for healthcare marketers, there are a number of ways AI is starting to optimize our workflows.

Healthcare 52

Healthcare Healthcare Patients Side effects 52

Clarivate

DECEMBER 14, 2023

Here are a few trends in life sciences and healthcare our analysts are keeping an eye on – and what they expect to see in 2024: Move over, oncology – metabolic drugs are the new hotness: The successful launches of Novo Nordisk’s Wegovy® and Eli Lilly’s Mounjaro® represent a revolutionary pharmacological breakthrough of rare proportions.

Pharma 111

Pharma Government Pharmacology Healthcare 111

PM360

SEPTEMBER 30, 2024

In late 2023, Deloitte found that over half of 105 surveyed global biopharma leaders were committed to reducing environmental impact and advancing sustainability by minimizing water use, sourcing sustainable materials, and overhauling supply chains.

Manufacturing 52

Manufacturing Pharma Pharmaceutical Competition 52

Clarivate

DECEMBER 19, 2022

Expansion opportunities for 2024 are relatively obvious, since the partners could expand to the three states with Walmart Health locations (Arkansas, Illinois, Texas ). Clarivate Associate Healthcare Research & Data Analysts Anubhav Sharma and Prashanth Jain contributed to this report. payer marketplace, please visit us here.

Competition 52

Competition Retail Insurance Marketing 52

Clarivate

OCTOBER 30, 2022

Of surveyed MCOs that cover or plan to cover DTx apps for the three conditions, more than 80% of respondents reported reimbursing DTx for at least one of the conditions in their fully insured commercial plans as of March 2022, with the remainder expecting to do so by 2024. Payers also noted some coverage in their Medicare and Medicaid plans.

Insurance 52

Insurance FDA Marketing Prescription 52

Clarivate

AUGUST 7, 2024

The three largest pharmacy benefit managers (PBMs) in the United States—Express Scripts, OptumRx and CVS Caremark—control more than 80% of the market share (per Clarivate data, as of January 2024). Click here to learn more about how Clarivate helps biopharma companies navigate market access across global markets.

Retail 59

Retail Marketing Competition Biopharma 59

European Pharmaceutical Review

APRIL 30, 2024

What are the top three trends that you are seeing in the biopharma manufacturing space? Let’s talk about continuous biopharma manufacturing. Speaking of your biopharma clients, what are you hearing about their main priorities? Sticking to the cell and gene therapy space, what’s your main prediction for 2024?

Manufacturing 97

Manufacturing Food and Drug Administration Biopharma Marketing 97

Clarivate

MAY 13, 2024

According to Clarivate’s latest enrollment data, as of January 2024, Medicaid enrollment had plummeted by nearly 9 million compared to six months prior. For 2024, 18% of enrollees were new to exchange coverage, according to the Centers for Medicare and Medicaid Services. million between January 2023 and January 2024. to about 2.5

Insurance 52

Insurance Marketing Healthcare Healthcare 52

Clarivate

MAY 8, 2024

A glance at the 2023 and early 2024 life science dealmaking environment shows fewer, but higher-value, transactions. Other partnerships of note include one for a couple of Shanghai-based Elpiscience Biopharma Ltd’s preclinical bispecific antibody assets, licensed by Tokyo-based Astellas Pharma Inc, with the option to license two more.

Pharma 59

Pharma Biopharma Prospecting Competition 59

PM360

OCTOBER 18, 2024

Mathai: There is no better time to join the biopharmaceutical industry than now, whether the company is small or large, intending to make medicines or in healthcare services or diagnostic companies. v=M25xiFblCbE ) JPM 2024: FogPharma’s new CEO, Mathai Mammen, unveils ‘contrarian.’ www.youtube.com/watch?v=M25xiFblCbE

Medicine 52

Medicine Education Prospecting Networking 52

PM360

JUNE 24, 2024

Yet, reaching and engaging such niche patient populations and the healthcare professionals (HCPs) who service them can be a challenge. How many touchpoints does the patient have with the healthcare system and which stakeholders do they interact with the most? It all starts with deeply understanding the patient journey.

Patients 118

Patients Education Healthcare Healthcare 118

PM360

AUGUST 7, 2024

Whether you’re a social media manager aiming to enhance engagement, a medical affairs professional measuring the impact of healthcare initiatives, or a marketer refining campaign effectiveness, it is important to understand how to create the best possible outcome for your campaigns and programs.

Media 52

Media Education Physicians Marketing 52

PM360

OCTOBER 22, 2024

DANNY SIGURDSON CEO and Founder Courier Health To effectively engage patients and prescribers to improve overall adherence to prescribed medication regimens, biopharma companies first need the visibility and full context of where a patient stands in their treatment journey. Support healthcare providers in a real and personal way.

Education 52

Education Side effects Medical Patients 52

Clarivate

OCTOBER 7, 2024

Online] Available at: [link] [Accessed 1 10 2024]. The need for considerable research and funding for developing and validating alternative methods may also be an issue (Nuwer, 2022; Anon., If you want to learn more about this solution, please visit Cortellis Drug Discovery Intelligence Platform | Clarivate or contact us. Works cited Anon.,

Food and Drug Administration 52

Food and Drug Administration Pharmacology Food Engineering 52

Clarivate

AUGUST 20, 2024

Announced on August 15, 2024, this first batch of Maximum Fair Prices (MFPs) were mandated by the Inflation Reduction Act of 2022 , which allowed CMS to negotiate what it describes as the maximum fair price for therapies representing the greatest cost to Medicare.

Manufacturing 52

Manufacturing Government Prescription Pharmaceutical manufacturing 52

Pharmaceutical Technology

JANUARY 25, 2023

In December 2022, AEON Biopharma, a biopharmaceutical company, announced its plans to go public through a merger with the SPAC Priveterra Acquisition Corp. Morgan Healthcare Conference in San Francisco, which finished on January 12. In 2022, another partnership between AbbVie and Morphic was also dropped. range in December 2022.

Marketing 69

Marketing Biopharma Pharma Competition 69